MAP Pharmaceuticals (NASDAQ:MAPP.DL)

CAPS Rating: No stars

Pharmaceutical Preparations


Player Avatar TMFBlacknGold (98.72) Submitted: 12/21/2012 9:44:06 AM : Underperform Start Price: $15.08 MAPP.DL Score: -53.84

MAP has no revenue and is losing large amounts of money each quarter (four in a row now). Before the recent financing deal it was worth less than $14 million on paper. Even now its worth less than $60 million, which doesn't support a $540 million market cap.

Featured Broker Partners